US Patent 11913013 Chimpanzee adenoviral vector-based filovirus vaccines
Patent 11913013 was granted and assigned to Sabin Vaccine Institute on February, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+24 properties)
Article (+334 characters)
US Patent 11913013 Chimpanzee adenoviral vector-based filovirus vaccines
Article
Patent abstract
This invention provides vaccines for inducing an immune response and protection against filovirus infection for use as a preventative vaccine in humans. In particular, the invention provides chimpanzee adenoviral vectors expressing filovirus proteins from different strains of Ebolavirus (EBOV) or Marburg virus (MARV).
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Alfredo Nicosia0
Cheng Cheng0
Clement Asiedu0
Gary J. Nabel0
Nancy J. Sullivan0
Riccardo Cortese0
Stefano Colloca0
Virginia Ammendola0
Date of Patent
February 27, 2024
0Patent Application Number
173894210
Date Filed
July 30, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11913013 Chimpanzee adenoviral vector-based filovirus vaccines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
